Cell Culture – Products

ProBioGen’s GlymaxX technology supports the FDA-approved Ziihera® antibody for HER2-positive biliary tract cancer, advancing targeted therapies.

This application note highlights the successful 5-fold scale-up of a high-cell density E. coli process from an established 200 L stainless steel fermenter to a 1000 L single-use system.

HC Corporation has launched a new high-heat CO2 incubator that offers enhanced contamination protection through its inCu-saFe chamber and SafeCell UV-LED bulb.

Terumo BCT and KBIOHealth have signed an MOU to develop workforce training for cell and gene therapy manufacturing in Korea. The program will focus on CAR-T and MSC therapy production using automated systems like Quantum Flex.

Asimov and LOTTE BIOLOGICS announced a strategic partnership focused on accelerating cell line development and scaling to GMP manufacturing, having demonstrated successful scale-up.

The IntelliXcap S1 from Azenta Life Sciences streamlines tube handling for various large-format tubes, automating sealing with consistent torque.

On February 28, 2025, WHO announced the recommended strains for the 2025-2026 northern hemisphere influenza season.

AMSBIO has launched GMP grade StemFit® for Differentiation - a chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells.

ProBioGen and Marea Therapeutics, Inc., a clinical-stage biotechnology company, announced the successful completion of a sprint project to deliver clinical material.

Stem cells can self-renew and differentiate, with potential for treating diseases like cancer and heart disease. Cytokines aid in this process. Sino Biological provides recombinant cytokines and research reagents.